SPI Pharma Inc. a leader in biopharmaceutical excipient and adjuvant systems, and Inimmune Corp., a biotechnology company specializing in the discovery and development of innate immune modulators, have partnered to develop and commercialize advanced adjuvant systems for vaccine development. This collaboration leverages Inimmune’s expertise in adjuvant formulation and immunotherapeutics and SPI Pharma’s manufacturing and global commercial capabilities. Adjuvant systems are cri...